Drug Profile
DRF ACXX
Alternative Names: DRF-3188; DRF-ACXXLatest Information Update: 08 Feb 2008
Price :
$50
*
At a glance
- Originator Dr Reddys Research Foundation
- Class Antineoplastics; Antivirals
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer; Viral infections
Most Recent Events
- 31 Jan 2003 Suspended - Preclinical for Cancer in India (unspecified route)
- 31 Jan 2003 Suspended - Preclinical for Viral infections in India (unspecified route)
- 23 Nov 2000 Preclinical development for Cancer in India (Unknown route)